Editorial - High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)5178-5179
Number of pages2
JournalEuropean Review for Medical and Pharmacological Sciences
Volume24
Issue number9
DOIs
StatePublished - 2020

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this